4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
TenNor Therapeutics (Suzhou) Limited (6872) operates in the Biotechnology industry and is headquartered in Suzhou, China with about 56 employees. Its market capitalization is roughly HK$6 billion. In the fiscal year ended 2025-12-31, 6872 reported CNY 0M in revenue and (CNY 153M) in net income.
TenNor Therapeutics (Suzhou) Limited engages in discovery, development and commercialization of differentiated therapies for diseases associated with bacterial infections and bacterial metabolism.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | CNY 0M | CNY 0M | CNY 0M |
| Operating Income (EBIT) | (CNY 101M) | (CNY 78M) | (CNY 123M) |
| Net Income | (CNY 153M) | (CNY 146M) | (CNY 192M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2025-12-31 |
|---|---|
| Total Revenue | CNY 0M |
| Operating Income (EBIT) | (CNY 20M) |
| Net Income | (CNY 38M) |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Assets | CNY 227M | CNY 133M | CNY 96M |
| Total Liabilities | CNY 73M | CNY 1.0B | CNY 855M |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6872 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms